- Many years of failure to deliver a financial outcome to shareholders by way of the sale of a technology (her job, which is paid for by shareholder funds).
- Shelved trials and products (her-vaxx, b-cell) after costing millions and going nowhere.
- Failure to meet self-set deadlines for data release.
- Dishonesty regarding cash runways and need for funding when asked.
- Members of her team, under her oversight, failing to do their jobs yet receiving exorbitant wages and share bonuses. She is failing as a leader.
- Share price down 94% since all-time highs.
Is Leslie's continued employment as MD and CEO tenable? In the real world, outside of the ASX fairyland casino, Leslie would have been shown the door years ago.
Why are we putting up with this? Leslie should be provided with a deadline to achieve a tangible financial result and if not met, she should be replaced with prejudice.
Thoughts?
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.45M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 27.0¢ | 25.5¢ | $470.1K | 1.794M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 106989 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 133372 | 25 |
View Market Depth
| Last trade - 15.17pm 11/08/2025 (20 minute delay) ? |
| IMU (ASX) Chart |